Human medicines

Cardiofort

Recall | Medicines | 11/10/2011

The distributor has informed its supplied customers by letter dated 04.10.2011 that the affected batch has a labeling error: On the folding boxes, the…

Cardiofort Read more

Croma

Medicines | 10/10/2011

Ophthalmologists have informed the Federal Office for Safety in Health Care that the drug Flurekain "Croma" Eye Drops is no longer available.

See…

Croma Read more

Nutriflex

Recall | Medicines | 16/09/2011

The marketing authorization holder informed its supplied customers in a letter dated September 15, 2011, that crystalline particles may be present in…

Nutriflex Read more

Vimpat

Recall | Medicines | 15/09/2011

The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed its supplied customers by fax dated September…

Vimpat Read more

Prezista

Replacement | Medicines | 08/09/2011

The marketing authorization holder informed its supplied customers in a letter dated 07.09.2011 that due to individual reports of an unpleasant, moldy…

Prezista Read more

Cardiolite/Neurolite

Recall | Medicines | 30/08/2011

The distribution company has informed its supplied customers by letter dated August 29, 2011, that the batches indicated above may be contaminated…

Cardiolite/Neurolite Read more

Calcium "Fresenius" - Ampullen

Replacement | Medicines | 24/08/2011

The marketing authorization holder has informed its supplied customers by letter dated 23.08.2011 that a replacement will be carried out due to…

Calcium "Fresenius" - Ampullen Read more

Enapril

Replacement | Medicines | 16/08/2011

The marketing authorization holder informed its supplied customers in a letter dated August 12, 2011, that individual tablets may break when they are…

Enapril Read more

Saroten Retard

Replacement | Medicines | 09/08/2011

The marketing authorization holder informed its supplied customers in a letter dated August 9, 2011, that the release of the active ingredient may be…

Saroten Retard Read more

Lasix

Replacement | Medicines | 15/07/2011

The marketing authorization holder informed its supplied customers in a letter dated July 7, 2011, that another batch that had exceeded the 18-month…

Lasix Read more
Email

Further inquiry note